Revolution Medicines (RVMDW) Receivables (2020 - 2023)
Revolution Medicines (RVMDW) posted quarterly Receivables of $1.3 million for Q4 2023, down 73.16% year-over-year from $4.7 million in Q4 2022, and up 305.83% quarter-over-quarter from $309000.0 in Q3 2023.
Revolution Medicines (RVMDW) Receivables (2020 - 2023) Analysis & Trends
Revolution Medicines' Receivables history runs 4 years deep, the most recent figure standing at $1.3 million for Q4 2023.
- In Q4 2023, Receivables fell 73.16% year-over-year to $1.3 million; the TTM figure through Dec 2023 stood at $1.3 million (down 73.16% YoY), while the FY2023 annual figure was $1.3 million, down 73.16% from the prior year.
- Receivables for Q4 2023 stood at $1.3 million, up from $309000.0 in the prior quarter.
- The five-year high for Receivables was $12.8 million in Q4 2020, with the low at $309000.0 in Q3 2023.
- The 4-year median for Receivables is $5.4 million (2022), against an average of $5.3 million.
- The sharpest annual moves came in 2022 and 2023: Receivables decreased 13.83% in 2022, then tumbled 93.74% in 2023.
- Revolution Medicines' Receivables stood at $12.8 million in 2020, then tumbled by 53.63% to $5.9 million in 2021, then slipped by 21.18% to $4.7 million in 2022, then sank by 73.16% to $1.3 million in 2023.
- Business Quant data shows RVMDW's Receivables at $1.3 million in Q4 2023, $309000.0 in Q3 2023, and $2.5 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Revolution Medicines | 2.45 Bn | 2.45 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.25 Mn |
| Sep 30, 2023 | 309,000.00 |
| Jun 30, 2023 | 2.51 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Dec 31, 2022 | 4.67 Mn |
| Sep 30, 2022 | 4.94 Mn |
| Jun 30, 2022 | 5.62 Mn |
| Mar 31, 2022 | 5.38 Mn |
| Dec 31, 2021 | 5.93 Mn |
| Sep 30, 2021 | 7.41 Mn |
| Jun 30, 2021 | 6.53 Mn |
| Mar 31, 2021 | 7.56 Mn |
| Dec 31, 2020 | 12.79 Mn |